Burcu Isler

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

ANZ journal of surgery

Antimicrobial agents and chemotherapy

JAC-antimicrobial resistance

The Journal of antimicrobial chemotherapy

Istanbul Egitim ve Arastirma Hastanesi

Hacettepe Üniversitesi Tıp Fakültesi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istanbul Egitim ve Arastirma Hastanesi Aug 01 2012 - Nov 14 2018

Turkey

Resident in Infectious Diseases and Clinical Microbiology :: Infectious Diseases and Clinical Microbiology

Lund University Mar 01 2010 - Aug 30 2011

Sweden

Research Fellow :: Clinical Microbiology

Karolinska Institutet Nov 01 2009 - Feb 28 2010

Sweden

Research Fellow in Gene and Cell Therapy :: Department of Medicine

Education History

Hacettepe Üniversitesi Tıp Fakültesi Oct 06 2003 - Jun 29 2009

Turkey

PHD

Publications

Burcu Isler, Natalie Niessen, David Campbell, Andrew D Toms, Nick Daneman, Laurens Manning, Joshua Saul Davis
Addressing important evidence gaps in the management of prosthetic joint infection: clinician attitudes and equipoise. ANZ journal of surgery 94 (7-8) (2024)
Burcu Isler, Natalie Niessen, David Campbell, Andrew D Toms, Nick Daneman, Laurens Manning, Joshua Saul Davis
Addressing important evidence gaps in the management of prosthetic joint infection: clinician attitudes and equipoise. ANZ journal of surgery (2024)
Burcu Isler, Patrick N A Harris, Adam G Stewart, David L Paterson
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa--authors' response. The Journal of antimicrobial chemotherapy 76 (12) (2021)
David L Paterson, Burcu Isler, Patrick N A Harris
PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales. JAC-antimicrobial resistance 3 (1) (2021)
Burcu Isler, Yukiko Ezure, Jose Luis García-Fogeda Romero, Patrick Harris, Adam G Stewart, David L Paterson
Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing Enterobacterales?: a Systematic Review and Meta-analysis. Antimicrobial agents and chemotherapy 65 (1) (2020)
Burcu Isler, Timothy J Kidd, Adam G Stewart, Patrick Harris, David L Paterson
Achromobacter Infections and Treatment Options. Antimicrobial agents and chemotherapy 64 (11) (2020)

Burcu Isler.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Burcu Isler